Janus Henderson Group plc 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 10:36 am Sale | 2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 1,481,170 4.400% | -506,325 (-25.48%) | Filing |
| 2022-09-12 08:25 am Sale | 2022-08-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 1,987,495 5.800% | -1,786,808 (-47.34%) | Filing |
| 2022-02-10 3:21 pm Sale | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 3,774,303 10.900% | -1,313,206 (-25.81%) | Filing |
| 2021-02-11 4:36 pm Purchase | 2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | JANUS HENDERSON GROUP PLC JHG | 5,087,509 14.700% | 585,160 (+13.00%) | Filing |